OptiBiotix to trade new shares on AIM (London)

OptiBiotix Health has been notified by from warrant holders to exercise warrants over 16,351 ordinary shares of 2p each in the company at an exercise price of 8p per share, providing OptiBiotix with gross proceeds of £1,308.

Application will be made to the London Stock Exchange to admit the 16,351 new ordinary shares to trading on AIM.  The company said the admission of the new ordinary shares is expected to occur on or around February 13, 2017.  The new ordinary shares will rank pari passu with the existing ordinary shares.